专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20070142351A1 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands 失效
标题翻译：新型杂环酰胺衍生物及其作为多巴胺D3受体配体的用途
公开(公告)号：US20070142351A1
公开(公告)日：2007-06-21
申请号：US11643594
申请日：2006-12-21
申请人： James Hendrix , Joseph Strupczewski , Kenneth Bordeau , Matthias Urmann , Gregory Shutske , Horst Hemmerte , John Jurcak , Harpal Gill , Franz Weiberth , Thaddeus Nieduzak , Sharon Jackson , Xu-Yang Zhao , Paul Mueller
发明人： James Hendrix , Joseph Strupczewski , Kenneth Bordeau , Matthias Urmann , Gregory Shutske , Horst Hemmerte , John Jurcak , Harpal Gill , Franz Weiberth , Thaddeus Nieduzak , Sharon Jackson , Xu-Yang Zhao , Paul Mueller
IPC分类号： A61K31/498 , A61K31/46 , C07D451/02 , C07D487/04
CPC分类号： C07D249/08 , C07D231/12 , C07D233/56 , C07D333/58 , C07D333/66 , C07D333/68 , C07D333/70 , C07D409/04 , C07D409/12 , C07D409/14 , C07D413/04 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D451/02 , C07D471/04 , C07D495/04
摘要： The invention relates to heterocyclic substituted amide derivatives that display selective binding to dopamine D3 receptors. In another aspect, the invention relates to a method for treating central nervous system disorders associated with the dopamine D3 receptor activity in a patient in need of such treatment comprising administering to the subject a therapeutically effective amount of said compounds for alleviation of such disorder. The central nervous system disorders that may be treated with these compounds include Psychotic Disorders, Substance Dependence, Substance Abuse, Dyskinetic Disorders (e.g. Parkinson's Disease, Parkinsonism, Neuroleptic-Induced Tardive Dyskinesia, Gilles de la Tourette Syndrome and Huntington's Disease), Dementia, Anxiety Disorders, Sleep Disorders, Circadian Rhythm Disorders and Mood Disorders. The subject invention is also directed towards processes for the preparation of the compounds described herein as well as methods for making and using the compounds as imaging agents for dopamine D3 receptors.
摘要翻译：本发明涉及显示与多巴胺D 3受体的选择性结合的杂环取代的酰胺衍生物。另一方面，本发明涉及在需要这种治疗的患者中治疗与多巴胺D 3 N 3受体活性相关的中枢神经系统障碍的方法，包括向所述受试者施用治疗有效量的所述用于缓解这种病症的化合物。可能用这些化合物治疗的中枢神经系统疾病包括心理障碍，物质依赖性，物质滥用，运动障碍（例如帕金森病，帕金森综合征，神经灵敏诱导的迟发性运动障碍，杜氏综合征和亨廷顿疾病），痴呆，焦虑疾病，睡眠障碍，昼夜节律紊乱和情绪障碍。本发明还涉及制备本文所述化合物的方法以及制备和使用化合物作为多巴胺D 3受体的显像剂的方法。

2. 发明申请

US20050107389A1 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands 审中-公开
标题翻译：新型杂环酰胺衍生物及其作为多巴胺D3受体配体的用途
公开(公告)号：US20050107389A1
公开(公告)日：2005-05-19
申请号：US10960399
申请日：2004-10-07
申请人： James Hendrix , Joseph Strupczeski , Kenneth Bordeau , Matthias Urmann , Gregory Shutske , Horst Hemmerle , John Jurcak , Harpal Gill , Franz Weiberth , Thaddeus Nieduzak , Sharon Jackson , Xu-Yang Zhao , Paul Mueller
发明人： James Hendrix , Joseph Strupczeski , Kenneth Bordeau , Matthias Urmann , Gregory Shutske , Horst Hemmerle , John Jurcak , Harpal Gill , Franz Weiberth , Thaddeus Nieduzak , Sharon Jackson , Xu-Yang Zhao , Paul Mueller
IPC分类号： A61K31/33 , C07D333/58 , C07D333/66 , C07D333/68 , C07D409/04 , C07D409/12 , C07D409/14 , C07D413/04 , C07D413/12 , C07D417/12 , C07D417/14 , C07D451/02 , C07D471/04 , C07D495/04 , C07D498/04 , C07D521/00 , C07D471/02 , A61K31/4745 , A61K31/503 , C07D487/04
CPC分类号： A61K31/33 , C07D231/12 , C07D233/56 , C07D249/08 , C07D333/58 , C07D333/66 , C07D333/68 , C07D409/04 , C07D409/12 , C07D409/14 , C07D413/04 , C07D413/12 , C07D417/12 , C07D417/14 , C07D451/02 , C07D471/04 , C07D495/04
摘要： The invention relates to heterocyclic substituted amide derivatives that display selective binding to dopamine D3 receptors. In another aspect, the invention relates to a method for treating central nervous system disorders associated with the dopamine D3 receptor activity in a patient in need of such treatment comprising administering to the subject a therapeutically effective amount of said compounds for alleviation of such disorder. The central nervous system disorders that may be treated with these compounds include Psychotic Disorders, Substance Dependence, Substance Abuse, Dyskinetic Disorders (e.g. Parkinson's Disease, Parkinsonism, Neuroleptic-Induced Tardive Dyskinesia, Gilles de la Tourette Syndrome and Huntington's Disease), Dementia, Anxiety Disorders, Sleep Disorders, Circadian Rhythm Disorders and Mood Disorders. The subject invention is also directed towards processes for the preparation of the compounds described herein as well as methods for making and using the compounds as imaging agents for dopamine D3 receptors.
摘要翻译：本发明涉及显示与多巴胺D 3受体的选择性结合的杂环取代的酰胺衍生物。另一方面，本发明涉及在需要这种治疗的患者中治疗与多巴胺D 3 N 3受体活性相关的中枢神经系统障碍的方法，包括向所述受试者施用治疗有效量的所述用于缓解这种病症的化合物。可能用这些化合物治疗的中枢神经系统疾病包括心理障碍，物质依赖性，物质滥用，运动障碍（例如帕金森病，帕金森综合征，神经灵敏诱导的迟发性运动障碍，杜氏综合征和亨廷顿疾病），痴呆，焦虑疾病，睡眠障碍，昼夜节律紊乱和情绪障碍。本发明还涉及制备本文所述化合物的方法以及制备和使用化合物作为多巴胺D 3受体的显像剂的方法。

3. 发明申请

US20070161641A1 Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands 失效
标题翻译：新型杂环取代的羰基衍生物及其作为多巴胺D3受体配体的用途
公开(公告)号：US20070161641A1
公开(公告)日：2007-07-12
申请号：US11714047
申请日：2007-03-05
申请人： James Hendrix , Horst Hemmerle , Matthias Urmann , Gregory Shutske , Joseph Strupczewski , Kenneth Bordeau , John Jurcak , Thaddeus Nieduzak , Sharon Jackson , Paul Angell , James Carey , George Lee , David Fink , Jean-Francois Sabuco , Yulin Chiang , Nicola Collar
发明人： James Hendrix , Horst Hemmerle , Matthias Urmann , Gregory Shutske , Joseph Strupczewski , Kenneth Bordeau , John Jurcak , Thaddeus Nieduzak , Sharon Jackson , Paul Angell , James Carey , George Lee , David Fink , Jean-Francois Sabuco , Yulin Chiang , Nicola Collar
IPC分类号： A61K31/498 , A61K31/497 , A61K31/496
CPC分类号： A61K31/496 , C07D209/08 , C07D213/74 , C07D215/40 , C07D231/12 , C07D233/56 , C07D239/42 , C07D241/04 , C07D241/20 , C07D249/08 , C07D261/20 , C07D295/14 , C07D295/155 , C07D307/66 , C07D307/68 , C07D317/58 , C07D333/58 , C07D333/66 , C07D401/04 , C07D401/14 , C07D403/04 , C07D403/12 , C07D405/04 , C07D409/04 , C07D409/12 , C07D409/14 , C07D413/04 , C07D413/12 , C07D413/14 , C07D471/06 , C07D495/04 , C07D498/04
摘要： The invention relates to heterocyclic substituted carbonyl derivatives that display selective binding to dopamine D3 receptors. In another aspect, the invention relates is to a method for treating central nervous system disorders associated with the dopamine D3 receptor activity in a patient in need of such treatment comprising administering to the subject a therapeutically effective amount of said compounds for alleviation of such disorder. The central nervous system disorders that may be treated with these compounds include Psychotic Disorders, Substance Dependence, Substance Abuse, Dyskinetic Disorders (e.g. Parkinson's Disease, Parkinsonism, Neuroleptic-Induced Tardive Dyskinesia, Gilles de la Tourette Syndrome and Huntington's Disease), Dementia, Anxiety Disorders, Sleep Disorders, Circadian Rhythm Disorders and Mood Disorders. The subject invention is also directed towards processes for the preparation of the compounds described herein as well as methods for making and using the compounds as imaging agents for dopamine D3 receptors.
摘要翻译：本发明涉及显示与多巴胺D 3受体的选择性结合的杂环取代的羰基衍生物。另一方面，本发明涉及在需要这种治疗的患者中治疗与多巴胺D 3 N 3受体活性相关的中枢神经系统障碍的方法，包括向受试者施用治疗有效量的所述化合物用于缓解这种病症。可能用这些化合物治疗的中枢神经系统疾病包括心理障碍，物质依赖性，物质滥用，运动障碍（例如帕金森病，帕金森综合征，神经灵敏诱导的迟发性运动障碍，杜氏杜勒氏综合征和亨廷顿病），痴呆，焦虑疾病，睡眠障碍，昼夜节律紊乱和情绪障碍。本发明还涉及制备本文所述化合物的方法以及制备和使用化合物作为多巴胺D 3受体的显像剂的方法。

4. 发明授权

US07772252B2 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands 失效
标题翻译：杂环取代的羰基衍生物及其作为多巴胺D3受体配体的用途
公开(公告)号：US07772252B2
公开(公告)日：2010-08-10
申请号：US12425731
申请日：2009-04-17
申请人： James Hendrix , Horst Hemmerle , Matthias Urmann , Gregory M Shutske , Joseph T Strupczewski , Kenneth J Bordeau , John G Jurcak , Thaddeus Nieduzak , Sharon A. Jackson , Paul Angell , James P Carey , George Lee , David Fink , Jean-Francois Sabuco , Yulin Chiang , Nicola Collar
发明人： James Hendrix , Horst Hemmerle , Matthias Urmann , Gregory M Shutske , Joseph T Strupczewski , Kenneth J Bordeau , John G Jurcak , Thaddeus Nieduzak , Sharon A. Jackson , Paul Angell , James P Carey , George Lee , David Fink , Jean-Francois Sabuco , Yulin Chiang , Nicola Collar
IPC分类号： A61K31/4535 , C07D409/04 , C07D409/14 , C07D495/04
CPC分类号： A61K31/496 , C07D209/08 , C07D213/74 , C07D215/40 , C07D231/12 , C07D233/56 , C07D239/42 , C07D241/04 , C07D241/20 , C07D249/08 , C07D261/20 , C07D295/14 , C07D295/155 , C07D307/66 , C07D307/68 , C07D317/58 , C07D333/58 , C07D333/66 , C07D401/04 , C07D401/14 , C07D403/04 , C07D403/12 , C07D405/04 , C07D409/04 , C07D409/12 , C07D409/14 , C07D413/04 , C07D413/12 , C07D413/14 , C07D471/06 , C07D495/04 , C07D498/04
摘要： The invention relates to heterocyclic substituted carbonyl derivatives that display selective binding to dopamine D3 receptors. In another aspect, the invention relates to a method for treating central nervous system disorders associated with the dopamine D3 receptor activity in a patient in need of such treatment comprising administering to the subject a therapeutically effective amount of said compounds for alleviation of such disorder. The central nervous system disorders that may be treated with these compounds include Psychotic Disorders, Substance Dependence, Substance Abuse, Dyskinetic Disorders (e.g. Parkinson's Disease, Parkinsonism, Neuroleptic-Induced Tardive Dyskinesia, Gilles de la Tourette Syndrome and Huntington's Disease), Dementia, Anxiety Disorders, Sleep Disorders, Circadian Rhythm Disorders and Mood Disorders. The subject invention is also directed towards processes for the preparation of the compounds described herein as well as methods for making and using the compounds as imaging agents for dopamine D3 receptors.
摘要翻译：本发明涉及显示与多巴胺D3受体的选择性结合的杂环取代的羰基衍生物。另一方面，本发明涉及一种治疗需要这种治疗的患者中与多巴胺D3受体活性相关的中枢神经系统障碍的方法，其包括向受试者施用治疗有效量的所述化合物以减轻这种病症。可能用这些化合物治疗的中枢神经系统疾病包括心理障碍，物质依赖性，物质滥用，运动障碍（例如帕金森病，帕金森综合征，神经灵敏诱导的迟发性运动障碍，杜氏综合征和亨廷顿疾病），痴呆，焦虑疾病，睡眠障碍，昼夜节律紊乱和情绪障碍。本发明还涉及本文所述化合物的制备方法以及制备和使用化合物作为多巴胺D3受体的显像剂的方法。

5. 发明授权

US07521445B2 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands 失效
标题翻译：杂环取代的羰基衍生物及其作为多巴胺D3受体配体的用途
公开(公告)号：US07521445B2
公开(公告)日：2009-04-21
申请号：US11714047
申请日：2007-03-05
申请人： James Hendrix , Horst Hemmerle , Matthias Urmann , Gregory M Shutske , Joseph T Strupczewski , Kenneth J Bordeau , John G Jurcak , Thaddeus Nieduzak , Sharon A. Jackson , Paul Angell , James P Carey , George Lee , David Fink , Jean-Francois Sabuco , Yulin Chiang , Nicola Collar
发明人： James Hendrix , Horst Hemmerle , Matthias Urmann , Gregory M Shutske , Joseph T Strupczewski , Kenneth J Bordeau , John G Jurcak , Thaddeus Nieduzak , Sharon A. Jackson , Paul Angell , James P Carey , George Lee , David Fink , Jean-Francois Sabuco , Yulin Chiang , Nicola Collar
IPC分类号： A61K31/5377 , A61K31/454 , A61K31/4535 , A61K31/4525 , C07D498/04 , C07D413/04 , C07D409/04
CPC分类号： A61K31/496 , C07D209/08 , C07D213/74 , C07D215/40 , C07D231/12 , C07D233/56 , C07D239/42 , C07D241/04 , C07D241/20 , C07D249/08 , C07D261/20 , C07D295/14 , C07D295/155 , C07D307/66 , C07D307/68 , C07D317/58 , C07D333/58 , C07D333/66 , C07D401/04 , C07D401/14 , C07D403/04 , C07D403/12 , C07D405/04 , C07D409/04 , C07D409/12 , C07D409/14 , C07D413/04 , C07D413/12 , C07D413/14 , C07D471/06 , C07D495/04 , C07D498/04
摘要： The invention relates to heterocyclic substituted carbonyl derivatives that display selective binding to dopamine D3 receptors. In another aspect, the invention relates to a method for treating central nervous system disorders associated with the dopamine D3 receptor activity in a patient in need of such treatment comprising administering to the subject a therapeutically effective amount of said compounds for alleviation of such disorder. The central nervous system disorders that may be treated with these compounds include Psychotic Disorders, Substance Dependence, Substance Abuse, Dyskinetic Disorders (e.g. Parkinson's Disease, Parkinsonism, Neuroleptic-Induced Tardive Dyskinesia, Gilles de la Tourette Syndrome and Huntington's Disease), Dementia, Anxiety Disorders, Sleep Disorders, Circadian Rhythm Disorders and Mood Disorders. The subject invention is also directed towards processes for the preparation of the compounds described herein as well as methods for making and using the compounds as imaging agents for dopamine D3 receptors.
摘要翻译：本发明涉及显示与多巴胺D3受体的选择性结合的杂环取代的羰基衍生物。另一方面，本发明涉及一种治疗需要这种治疗的患者中与多巴胺D3受体活性相关的中枢神经系统障碍的方法，其包括向受试者施用治疗有效量的所述化合物以减轻这种病症。可能用这些化合物治疗的中枢神经系统疾病包括心理障碍，物质依赖性，物质滥用，运动障碍（例如帕金森病，帕金森综合征，神经灵敏诱导的迟发性运动障碍，杜氏综合征和亨廷顿疾病），痴呆，焦虑疾病，睡眠障碍，昼夜节律紊乱和情绪障碍。本发明还涉及本文所述化合物的制备方法以及制备和使用化合物作为多巴胺D3受体的显像剂的方法。

6. 发明申请

US20050107377A1 Benzisoxazolyl-,pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists 失效
标题翻译：可用作D4拮抗剂的苯并异恶唑基 - ，吡啶并恶唑基和苯并噻吩基 - 苯氧基衍生物
公开(公告)号：US20050107377A1
公开(公告)日：2005-05-19
申请号：US10844245
申请日：2004-05-12
申请人： Gregory Shutske , James Hendrix , John Jurcak , Brian Freed , Nicholas Hrib , John Tomer , Reda Hanna
发明人： Gregory Shutske , James Hendrix , John Jurcak , Brian Freed , Nicholas Hrib , John Tomer , Reda Hanna
IPC分类号： A61K31/42 , A61K31/4745 , A61K31/496 , A61K31/5377 , C07D498/02
CPC分类号： C07D261/20 , C07D333/56 , C07D409/12 , C07D413/12 , C07D471/04 , C07D498/04
摘要： The compounds are of the class of benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives, useful as D4 antagonists. Said compounds are useful for the treatment of medical conditions mediated by inhibition of D4 receptor. These conditions comprise, for example, Attention Deficit Hyperactivity Disorder, Obsessive-Compulsive Disorder, Psychoses, Substance Abuse, Substance Dependence, Parkinson's Disease, Parkinsonism, Tardive Diskinesia, Gilles de la Tourette Syndrome, Conduct Disorder, and Oppositional Defiant Disorder. A further aspect of the invention is to provide a pharmaceutical composition, intermediates, and a method of making said class of compounds.
摘要翻译：这些化合物是苯并异恶唑基 - ，吡啶并恶唑基 - 和苯并噻吩基 - 苯氧基衍生物类，其可用作D 4 N 4拮抗剂。所述化合物可用于治疗通过抑制D 4受体介导的医学病症。这些病症包括例如注意力缺陷多动障碍，强迫症，精神病，药物滥用，物质依赖性，帕金森病，帕金森综合征，迟发性麻痹症，杜氏综合征，行为障碍和反对性反抗障碍。本发明的另一方面是提供药物组合物，中间体和制备所述类化合物的方法。

7. 发明申请

US20060026945A1 High-strength spun yarn produced from continuous high-modulus filaments, and process for making same 有权
标题翻译：由连续高模量长纤维生产的高强度短纤纱及其制造方法
公开(公告)号：US20060026945A1
公开(公告)日：2006-02-09
申请号：US10913930
申请日：2004-08-06
申请人： James Hendrix , Donald Hamrick , Harold Edwards
发明人： James Hendrix , Donald Hamrick , Harold Edwards
IPC分类号： D07B1/06 , D02G3/02
CPC分类号： D02G3/047 , D01G1/08
摘要： A process for making a high-strength spun yarn begins by feeding one or more tows of substantially uncrimped continuous filaments of high-modulus material having a tensile modulus exceeding about 20×106 psi through a high-speed stretch-breaking apparatus operating at low total draft ratio (preferably about 2.0) to break the filaments into high-modulus staple fibers having an average length in the range of about 5 to 6 inches. The tows advantageously are heavy, for example, having a denier of about 25,000 to about 500,000. Following the stretch-breaking step, the staple fibers are collected in sliver cans, and the staple fibers are advanced from the sliver cans to a spinning machine, where the fibers are spun into yarn. An important aspect of the invention is that no intermediate processes are performed between the stretch-breaking and spinning processes, which minimizes disruption of the alignment of and damage to the staple fibers.
摘要翻译：用于制造高强度纺织纱线的方法开始于将具有超过约20×10 -6 psi的拉伸模量的一个或多个基本上未卷曲的高模量材料的连续长丝的丝束通过高速拉伸 - 破裂装置以较低的总通风比（优选约2.0）操作，以将长丝断裂成具有在约5至6英寸范围内的平均长度的高模量短纤维。丝束有利地是重的，例如，具有约25,000至约500,000的旦尼尔。在拉伸断裂步骤之后，将短纤维收集在纱条中，并且将短纤维从棉条提前到纺丝机，其中纤维被纺丝成纱线。本发明的一个重要方面是在拉伸断裂和纺丝过程之间不进行中间工艺，这使得短纤维的对准和损坏的破坏最小化。

8. 发明授权

US07027158B2 Beam splitter/combiner for optical meterology tool 有权
公开(公告)号：US07027158B2
公开(公告)日：2006-04-11
申请号：US10229630
申请日：2002-08-28
申请人： James Hendrix , David Wang , Michael Ellison , Joel Ng
发明人： James Hendrix , David Wang , Michael Ellison , Joel Ng
IPC分类号： G01N21/45
CPC分类号： G01B11/0625 , G01N21/211 , G01N21/255 , G01N21/55 , G01N21/9501
摘要： A combiner for optical beams includes a substrate overlaid by a multi-layer dielectric film stack. The substrate is a clear material and the dielectric film stack is a series of alternating layer of high and low refractive index. This gives the combiner relatively high reflectivity across UV wavelengths and relatively high transmissivity in the visible and longer wavelengths and allows visible light to pass through the combiner while UV light is reflected. At the same time dielectric film stack has minimal absorption and scatter. This means that the intensity of visible light maintains at least 90% of its intensity as it passes through combiner and UV light retains at least 90% of its intensity as it is reflected by combiner.

9. 发明申请

US20060225796A1 Automated water shut-off valve 有权
标题翻译：自动关水阀
公开(公告)号：US20060225796A1
公开(公告)日：2006-10-12
申请号：US11099894
申请日：2005-04-07
申请人： James Hendrix
发明人： James Hendrix
IPC分类号： F16K7/06
CPC分类号： E03D1/00 , F16K37/0091 , G01F1/34 , G01F15/003 , G01M3/2815 , Y02A20/218 , Y10T137/7759 , Y10T137/7761 , Y10T137/8158 , Y10T137/86397
摘要： A device includes a housing that has a plurality of monolithically formed walls, wherein selected walls are provided with inlet and outlet ports respectively. The housing includes a coupling in fluid communication with the inlet and outlet ports, a mechanism for detecting a fluctuation in water pressure, and a mechanism for selectively prohibiting water flow. The prohibiting mechanism cooperates with the detecting mechanism. The housing also includes a mechanism for providing an audible notification when the water supply is toggled between interrupted and reinstated modes and a mechanism for manually controlling the prohibiting mechanism. The manually controlling mechanism is electrically coupled to the prohibiting mechanism. An internal power supply source supplies power to the detecting mechanism, the prohibiting mechanism, and the manually controlling mechanism. A diode is attached to the housing and is illuminable when the power supply source reaches a minimum threshold level.
摘要翻译：一种装置包括具有多个整体形成的壁的壳体，其中选定的壁分别设有入口和出口。壳体包括与入口和出口流体连通的联接器，用于检测水压波动的机构，以及用于选择性地禁止水流的机构。禁止机制与检测机构配合。壳体还包括当在中断和恢复模式之间切换供水时提供听觉通知的机构以及用于手动控制禁止机构的机构。手动控制机构电耦合到禁止机构。内部电源将检测机构，禁止机构和手动控制机构供电。二极管连接到壳体，并且当电源达到最小阈值电平时可以点亮二极管。

10. 发明申请

US20050108717A1 Systems and methods for creating an application group in a multiprocessor system 审中-公开
标题翻译：在多处理器系统中创建应用程序组的系统和方法
公开(公告)号：US20050108717A1
公开(公告)日：2005-05-19
申请号：US10715786
申请日：2003-11-18
申请人： Steve Hong , Matthew Munson , Thomas Valverde , Scott Geye , James Hendrix
发明人： Steve Hong , Matthew Munson , Thomas Valverde , Scott Geye , James Hendrix
IPC分类号： G06F9/50 , G06F9/46
CPC分类号： G06F9/5055 , G06F9/5033
摘要： A dynamic workload management system enables system administrators to easily identify installed applications and to assign them to affinity groupings in order of importance to the enterprise and to enable the system administrators to save and restore multiple configurations. The workload configuration is continually updated based on the hardware utilization measurements of the application groups that make up a workload configuration. The software interface of the system of the invention permits the system to dynamically add and remove processors to and from affinity masks that are automatically set up. This feature of the invention allows the application groups to consume CPU resources according to their priority.
摘要翻译：动态工作负载管理系统使系统管理员可以轻松地识别已安装的应用程序，并按照企业重要性将其分配给关联组，并使系统管理员能够保存和恢复多个配置。基于组成工作负载配置的应用程序组的硬件利用率测量，持续更新工作负载配置。本发明的系统的软件接口允许系统动态地向与自动建立的亲和掩模相加和去除处理器。本发明的该特征允许应用组根据其优先级消耗CPU资源。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式